Dr. Agarwal’s Health Care Revenue Surges 20.8% to ₹1,548 Crores in 9M’FY26
Dr. Agarwal’s Health Care Limited announced a significant 20.8% YoY increase in total income, reaching ₹1,548 Crores for the nine months…
SBI Life Q3 FY26 Earnings Conference Call Transcript
SBI Life reported a 19% growth in new business premium, reaching INR 313.3 billion. The company’s profit after tax increased by 4% to…
Aarti Drugs Declares Interim Dividend and Approves Key Personnel Changes
Aarti Drugs announced an interim dividend of ₹2 per equity share (20%) for the financial year 2025-26. The record date for the dividend is set…
Usha Martin Receives Cautionary Letter Regarding Shareholding Pattern
Usha Martin has received a cautionary letter from the exchange regarding its shareholding pattern for the quarter ended March 31, 2025. The…
Dishman Carbogen Amcis Q3 FY26 Results, Security Cover Report & Auditor Review
Dishman Carbogen Amcis Limited announced its Q3 FY26 financial results. Consolidated total income stood at ₹726.46 Crores. The company has…
Kansai Nerolac Q3 FY26 Results Show Revenue Growth, Impacted by New Labor Codes
Kansai Nerolac Paints Ltd (KNPL) announced its Q3 FY26 results, reporting a 3.5% increase in net revenue to ₹1907.35 Crores. EBITDA grew by…
Signature Global Reports Q3 & 9M FY2026 Financials, Pre-Sales Dip
Signature Global reported ₹2.8 billion revenue in Q3 FY26 and ₹14.9 billion for 9M FY26. Adjusted gross profit margin improved to 40% in Q3…
V2 Retail Limited Board Approves Stock Split and Authorised Capital Alteration
V2 Retail Limited’s Board of Directors has approved a stock split, dividing each share with a face value of ₹10 into ten shares with a…
Aarti Drugs Interim Dividend Declared for Financial Year 2025-26
Aarti Drugs has announced an interim dividend of ₹2 per share (20%) for the financial year 2025-26. The decision was made during a Board of…
Edelweiss Board Meeting to Consider Q3 Unaudited Financial Results
Edelweiss has announced a board meeting scheduled for February 10, 2026, to consider the unaudited financial results for the third quarter…